drug prices
Price controls are failing. We need a better way.
Government price controls mean fewer new breakthrough cures for patients and their families, less research on new cancer treatments, and hundreds of millions of lives cut short.
Lawmakers in Washington are reportedly making progress on a deal to impose price controls on pharmaceutical drugs, a scheme that would have disastrous consequences for cancer patients and their loved ones.
Government price controls mean a future with as many as 342 fewer new cures for cancer, Alzheimer’s, and other leading diseases
The new campaign comes as Congress prepares to revive drug price control provision included in last year’s failed “Build Back Better” plan.
Putting Washington in charge of drug prices would stifle innovation and lead to fewer life-saving cures.
“America – we lead the world in access to new drugs and cures for cancer, AIDS and COVID. But some in Washington would put that at risk with a 95 percent drug tax and a loss of control over the medicines you need.”
New YouGov/AFP survey shows voters prefer increasing market competition over price controls by more than 2-to-1 ratio. Arlington, Va. – Today, Americans for Prosperity released the results of a new survey conducted by YouGov on voter attitudes toward reducing the cost of prescription drugs. Nearly seven in ten voters (68%) agreed that to reduce costs, […]
